phase readout

NCT06992258: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

RECRUITINGupdated 9d ago

community read0 votes

Sponsor: Criterium, Inc.. Phase: PHASE2. Conditions: Colorectal Cancer

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1h ago

Found something off?